The therapy offers a promising new approach to tackling the growing challenge of antimicrobial resistance, said the study published in the international UK medical journal The Lancet Infectious Diseases in late September.

China: New Drug Used to Treat Common Infection! (19.11.2025)

A new treatment combination for Helicobacter pylori — a common stomach bacterium linked to ulcers and gastritis — based on a domestically developed drug has shown comparable, and in some cases superior, efficacy in eradicating the infection compared with standard therapy, according to recent clinical research.

The therapy offers a promising new approach to tackling the growing challenge of antimicrobial resistance, said the study published in the international journal The Lancet Infectious Diseases in late September.

The experimental triple therapy centres on rifasutenizol, a novel antimicrobial agent developed specifically for H. pylori infection by Tennor Therapeutics, a pharmaceutical company based in Suzhou, Jiangsu province.

Jessica Brady contacted her GP practice more than 20 times feeling unwell

NHS: Privatising GPs Told to “Stop Killing Patients” Unnecessarily! (23.9.2025)

The Department of Health said many GP practices already used the correct approach, but that Jess’ s Rule would make this “standard practice across the country”.

Health and Social Care Secretary Wes Streeting thanked Jess’s family, saying they had campaigned tirelessly through “unimaginable grief” to ensure Jessica’s legacy helps to save the lives of others.

“Patient safety must be the bedrock of the NHS, and Jess’s Rule will make sure every patient receives the thorough, compassionate, and safe care that they deserve, while supporting our hard-working GPs to catch potentially deadly illnesses,” he said.

Paul Callaghan, from Healthwatch England, which represents people who use health and social care services, said the rule should be implemented “quickly and consistently”.

“It’s also imperative that specialist teams have the resources to deal with potential increases in demand, resulting from increased referrals,” he said.

Socialist Science - Diabetes Treatment

China: Diabetes – Monitoring of Blood Glucose Revolutionized! (10.2.2025)

Diabetes is a serious public health problem, affecting more than 500 million people around the world. The prevalence of diabetes among adults in China is as high as 12 percent, according to national data from last year.

Effective and regular blood glucose monitoring is the foundation of diabetes management, and the commonly used blood glucose monitoring methods require invasive actions involving the skin, which may cause problems, such as pain and infection, and pose challenges for patients’ compliance with long-term monitoring.

Non-invasive blood glucose detection technology has been at the frontier of research in recent decades, but it has faced challenges in accuracy and versatility.